Skip to main content
Clinical Trials/RBR-72tgny
RBR-72tgny
Recruiting
Phase 1

Assessment of Primary Dermal Irritability, Dermal Irritability and Dermal Sensitization (HRIPT).

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Healthy Volunteers
Sponsor
Medcin Instituto da Pele Ltda.
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 7, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age between 18 and 70 years; Phototypes I, II, III and IV as adapted Fitzpatrick scale Annex 1; Skin of the whole test region;

Exclusion Criteria

  • Gestation or risk of gestation and / or lactation when women; Use of anti\-inflammatory drugs 30 days and / or immunosuppressants for up to three months prior to selection; Immunosuppression by drugs or active diseases;
  • Decompensated endocrinopathies; Personal history of atopy; Intense sun exposure or tanning sessions up to 15 days prior to evaluation or during the study period; Forecast of sea baths, swimming pool or sauna during the study; Practice water sports during the study; Dermographism; Use of oral or topical treatment with vitamin A acid and / or its derivatives up to 1 month before the start of the study; Aesthetic and / or dermatological treatment in the body within 03 weeks prior to selection; Scheduled vaccination during the study period or until 03 weeks prior to screening; History of sensitization and irritation to topical product; Active skin conditions (local and / or disseminated) that may interfere with the results of the study; Use of new drugs and / or cosmetics during the study; Skin reactivity; Previous participation in studies with the same product; Congenital or acquired immunodeficiency; Relevant clinical history or current evidence of alcohol or other drug abuse; Known or suspected intolerance of any ingredient in the study products test or comparative products; History of lack of adherence or unwillingness to adhere to the study protocol; Employees of Medcin or the sponsoring company involved in the study, or a close family member of an employee involved in the study. Other conditions considered by the researcher as reasonable for disqualification of study participation. If Yes, it should be described in observation in the clinical file;

Outcomes

Primary Outcomes

Not specified

Similar Trials